Nevertheless, as shown, patients with ATTR-CA (either wild-type or mutant) had better overall and HF-related prognosis compared to patients with AL-CA, findings which persisted even after the exclusion of patients with increased percentage of bone marrow plasma cells, an adverse prognostic factor in AL-CA [21]. The gene discussed is TTR; the disease is hydrops fetalis.